| Antony Joshua Hayes, MD | |
|
1970 E 53rd St, Davenport, IA 52807-2710 | |
| (563) 359-3949 | |
| (563) 359-1159 |
| Full Name | Antony Joshua Hayes |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 11 Years |
| Location | 1970 E 53rd St, Davenport, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467892133 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Medical Center-davenport | Davenport, IA | Hospital |
| Mercyone Clinton Medical Center | Clinton, IA | Hospital |
| Genesis Hlth System Dba Genesis Mdl Ctr-illini | Silvis, IL | Hospital |
| Genesis Medical Center-dewitt | Dewitt, IA | Hospital |
| Genesis Medical Center, Aledo | Aledo, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Group Pc Sc | 9032008537 | 20 |
News Archive
Most long-term survivors of retinoblastoma, particularly those who had been diagnosed with tumors by their first birthdays, have normal cognitive function as adults, according to a St. Jude Children's Research Hospital study. The research, which appears in the current issue of the journal Cancer, found that the vast majority of survivors work full time, live independently and fulfill other milestones of adult life.
DataMotion, an innovative health information service provider with more than 14 years of experience in secure data delivery, today announced that Medflow, Inc., the leading provider of electronic health records for ophthalmology, has selected its DataMotion Direct secure messaging service.
atients with relapsed or refractory follicular lymphoma who continue on maintenance rituximab therapy after chemotherapy have better overall survival than patients who do not receive this treatment, according to a meta-analysis of randomized trials in the February 10 online issue of the Journal of the National Cancer Institute.
A groundbreaking trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis (MS) has been shown to have possible benefits for the treatment of the disease.
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
› Verified 3 days ago
| Entity Name | Radiology Group Pc Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073573994 PECOS PAC ID: 9032008537 Enrollment ID: O20111128000781 |
News Archive
Most long-term survivors of retinoblastoma, particularly those who had been diagnosed with tumors by their first birthdays, have normal cognitive function as adults, according to a St. Jude Children's Research Hospital study. The research, which appears in the current issue of the journal Cancer, found that the vast majority of survivors work full time, live independently and fulfill other milestones of adult life.
DataMotion, an innovative health information service provider with more than 14 years of experience in secure data delivery, today announced that Medflow, Inc., the leading provider of electronic health records for ophthalmology, has selected its DataMotion Direct secure messaging service.
atients with relapsed or refractory follicular lymphoma who continue on maintenance rituximab therapy after chemotherapy have better overall survival than patients who do not receive this treatment, according to a meta-analysis of randomized trials in the February 10 online issue of the Journal of the National Cancer Institute.
A groundbreaking trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis (MS) has been shown to have possible benefits for the treatment of the disease.
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Antony Joshua Hayes, MD 1970 E 53rd St, Davenport, IA 52807-2710 Ph: (563) 359-3949 | Antony Joshua Hayes, MD 1970 E 53rd St, Davenport, IA 52807-2710 Ph: (563) 359-3949 |
News Archive
Most long-term survivors of retinoblastoma, particularly those who had been diagnosed with tumors by their first birthdays, have normal cognitive function as adults, according to a St. Jude Children's Research Hospital study. The research, which appears in the current issue of the journal Cancer, found that the vast majority of survivors work full time, live independently and fulfill other milestones of adult life.
DataMotion, an innovative health information service provider with more than 14 years of experience in secure data delivery, today announced that Medflow, Inc., the leading provider of electronic health records for ophthalmology, has selected its DataMotion Direct secure messaging service.
atients with relapsed or refractory follicular lymphoma who continue on maintenance rituximab therapy after chemotherapy have better overall survival than patients who do not receive this treatment, according to a meta-analysis of randomized trials in the February 10 online issue of the Journal of the National Cancer Institute.
A groundbreaking trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis (MS) has been shown to have possible benefits for the treatment of the disease.
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
› Verified 3 days ago
Dr. Christine M Sharis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1401 W Central Park Ave, Davenport, IA 52804 Phone: 563-421-1900 Fax: 563-421-1938 | |
John W Rogers, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1970 E 53rd St, Davenport, IA 52807 Phone: 563-359-3949 | |
Jason Benjamin Mueller, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1970 E 53rd St, Davenport, IA 52807 Phone: 563-359-3949 Fax: 563-355-1159 | |
Andrew E Berkow, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1970 E 53rd St, Davenport, IA 52807 Phone: 563-359-3949 | |
Dr. Antonio P Vigliotti, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1401 W Central Park Ave, Davenport, IA 52804 Phone: 563-421-1900 Fax: 563-421-1938 | |
Robert W Hartung, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1970 E 53rd St, Davenport, IA 52807 Phone: 563-359-3949 | |
Joseph M Phelan, MD Radiology Medicare: Medicare Enrolled Practice Location: 1970 E 53rd St, Davenport, IA 52807 Phone: 563-359-3949 |